# Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia

> **NCT00099528** · PHASE2 · UNKNOWN · sponsor: **Renovis** · enrollment: 90 (—)

## Conditions studied

- Neuralgia
- Shingles
- Peripheral Nervous System Disease

## Interventions

- **DRUG:** REN-1654

## Key facts

- **NCT ID:** NCT00099528
- **Lead sponsor:** Renovis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 90 (—)
- **Last updated:** 2010-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099528, "Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00099528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*